HDM1702
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
Huadong Medicine · Phase 3 · Recruiting · Enrollment 460
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| HDM1702 | Obesity or overweight | n/r | 16 | n/r | n/r |
| WEGOVY® | Obesity or overweight | n/r | 16 | n/r | n/r |